Form 4: Bicycle Therapeutics Executive Sells Shares to Cover Tax Obligations

Michael Skynner, Chief Technology Officer of Bicycle Therapeutics PLC, sold shares to cover statutory tax withholding obligations related to vesting restricted stock units.

Summary

• Michael Skynner, the Chief Technology Officer of Bicycle Therapeutics PLC, reported the sale of ordinary shares on April 2nd and 3rd, 2025.
• The sales were executed to cover statutory tax withholding obligations associated with the vesting and settlement of restricted stock units.
• On April 2nd, 814 shares were sold at a weighted average price of $8.02.
• On April 3rd, 1,038 shares were sold at a weighted average price of $7.48.
• Following these transactions, Skynner directly owns 121,870 ordinary shares.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (selling shares to cover taxes) and doesn't inherently indicate positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives.

Stakeholder Impact

• The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.

Key Dates

Keywords

Bicycle Therapeutics, BCYC, Michael Skynner, Form 4, Share Sale, Tax Withholding, Restricted Stock Units, Executive Compensation